INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 26 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,800 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2022 | $9,800 | -2.0% | 10,000 | 0.0% | 0.00% | – |
| Q3 2022 | $10,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2022 | $10,000 | +11.1% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $9,000 | -10.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $10,000 | +11.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $9,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $9,000 | +12.5% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $8,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $8,000 | +14.3% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $7,000 | -12.5% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $8,000 | -20.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $10,000 | +11.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $9,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 15,003,000 | $13,500,000 | 6.56% |
| PenderFund Capital Management Ltd. | 9,605,000 | $10,735,000 | 2.51% |
| Silver Point Capital L.P. | 38,808,000 | $34,151,000 | 1.87% |
| Benefit Street Partners LLC | 5,045,000 | $4,440,000 | 1.69% |
| Context Capital Management, LLC | 11,279 | $10,168,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 57,791,000 | $51,920,000 | 0.92% |
| DeepCurrents Investment Group LLC | 30,292,000 | $27,169,000 | 0.81% |
| Saltoro Capital, LP | 1,800,000 | $1,623,000 | 0.66% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,481,000 | $18,638,000 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 64,548,000 | $58,191,000 | 0.24% |